PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Endocrinology and Nutrition Service, Department of Medicine, Germans Trias i Pujol Health Science Research Institute and Hospital, Universitat Autònoma de Barcelona, Badalona, Spain.\', \'Department of Endocrinology, Hospital Universitario de la Princesa, Instituto de Investigación de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.\', \'Division of Endocrinology and Metabolism, Department of Internal Medicine, Hacettepe University School of Medicine, Hacettepe Ankara, Turkey.\', \'Institute of Endocrine and Metabolic Sciences, Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milano, Italy. giustina.andrea@hsr.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12020-021-02734-w
?:doi
?:hasPublicationType
?:journal
  • Endocrine
is ?:pmid of
?:pmid
?:pmid
  • 33963516
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.101
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all